SCHEMBL172048

SCHEMBL172048

CCC1(O)CCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14218658 0.85
SCHEMBL11756453 0.85
SCHEMBL17835268 0.83 MAPT (0.34)
SCHEMBL12488334 0.83 MAPT (0.34)
SCHEMBL17835272 0.83 MAPT (0.34)
SCHEMBL17835271 0.83 MAPT (0.34)
SCHEMBL19517328 0.77
SCHEMBL27265511 0.77
SCHEMBL4402767 0.77 GAA (0.32)
SCHEMBL4942467 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426124-A1 PROCESS FOR PRODUCING PYRIPYROPENE DERIVATIVE Meiji Seika Pharma Co., Ltd. (JP) 2012-03-07 EP disclosed
US-20110245514-A1 PROCESSES FOR THE PRODUCTION OF HYDROGENATED PRODUCTS BIOAMBER S.A.S. (CA) 2011-10-06 US disclosed
EP-2371798-A1 Processes for the production of tetrahydrofuran, gamma-butyrolactone and/or butanediol from salts of succinic acid BioAmber S.A.S. (CA) 2011-10-05 EP disclosed